CMPX 8-K 2026-11-09

Compass Therapeutics, Inc. (CMPX) 8-K dated 2026-11-09 — accession 0001171843-26-007256.

Compass Therapeutics, Inc. (CMPX) is a biotechnology company listed on US.

Compass Therapeutics, Inc. filed a 8-K on 2026-11-09. Accession 0001171843-26-007256.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CMPX revenue for 2025-12-31 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CMPX currently screens at market cap $367.4M.

Not investment advice. The CMPX SEC hub lists recent forms. The stock page is the research view.